Table 3.
Characteristics of the study group according to clinical stage of CRC.
| Variable | Total | Clinical stage | p | ||
|---|---|---|---|---|---|
| II (n = 51) | III (n = 65) | IV (n = 131) | |||
| Age (years) | 66.02 ± 9.20 | 65.29 ± 9.11 | 65.71 ± 9.66 | 66.46 ± 9.05 | 0.921 |
| BMI (kg/m2) | 26.24 ± 4.65 | 26.04 ± 4.44 | 26.78 ± 4.92 | 26.05 ± 4.61 | 0.695 |
| WBC (×109/L) | 6.89 (5.65–8.81) | 6.13 (5.47–8.01) | 6.28 (5.03–7.77) | 7.94 (6.10–10.08) | <0.0001 |
| NC (×109/L) | 4.38 (3.27–5.68) | 3.72 (2.69–4.70) | 3.56 (2.89–4.77) | 4.80 (3.74–6.48) | <0.0001 |
| PC (×109/L) | 276 (221–342) | 273 (229–342) | 264 (219–323) | 288 (220–374) | 0.152 |
| PLR | 158.5 (119.4–237.1) | 138.2 (106.4–207.5) | 150.8 (126.0–237.0) | 165.1 (125.0–250.9) | 0.158 |
| MPV (fL) | 8.1 (7.1–10.3) | 8.9 (7.1–10.2) | 7.9 (7.2–9.9) | 8.3 (7.1–10.5) | 0.742 |
| MPV/PC ratio | 0.030 (0.023–0.040) | 0.029 (0.025–0.043) | 0.032 (0.024–0.041) | 0.031 (0.021–0.039) | 0.308 |